Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Choroidal Detachment : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Glaucoma, Malignant

Melanoma, Choroidal

Pupillary Block, Aphakic

Pupillary Block, Pseudophakic

Retinal Detachment, Exudative

Retinal Detachment, Postoperative

Retinal Detachment, Tractional




Patient Education
Click here for patient education.



Author: Carlo E Traverso, MD, Associate Professor, University Eye Clinic, Genova; Consulting Staff and Head of Glaucoma and Cornea Clinical Unit, University of Genova Medical School, Italy

Carlo E Traverso is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and European Glaucoma Society

Editors: Richard W Allinson, MD, Associate Professor, Division of Ophthalmology, Texas A&M University Health Science Center, Associate Professor, Department of Surgery, Scott and White Clinic; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Steve Charles, MD, Director of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Author and Editor Disclosure

Synonyms and related keywords: serous choroidal detachment, choroidals, choroidal effusion, delayed suprachoroidal hemorrhage, nonexpulsive suprachoroidal hemorrhage, hemorrhagic choroidal detachment, expulsive hemorrhage, intraoperative choroidal detachment/hemorrhage, choroidal vascular plexus

Background

The suprachoroidal space is normally virtual because the choroid is in close apposition to the sclera. As fluid accumulates, this space becomes real, and the choroid is displaced from its normal position. Fluid accumulation, either serumlike or blood, also can occur within the choroid, which is a spongy tissue.

Serous choroidal detachment involves transudation of serum into the suprachoroidal space. This transudation may be due to increased transmural pressure, most frequently caused by globe hypotony of any etiology or trauma, or exudation of serum, most frequently caused by inflammation.

Hemorrhagic choroidal detachment is a hemorrhage in the suprachoroidal space or within the choroid caused by the rupture of choroidal vessels. This can occur spontaneously (rare), as a consequence of ocular trauma, during eye surgery, or after eye surgery. Except for posttraumatic cases, the clinical picture is very similar in all forms of choroidal detachment, the only difference being the time of presentation. The outcome is generally worse for intraoperative hemorrhages, which often are accompanied by loss of eye contents.

Pathophysiology

The exact triggering mechanism is unknown. An increase in transmural pressure in the choroidal vascular plexus can be caused by elevated blood pressure, low intraocular pressure (IOP), or a combination. An increase in vascular permeability is caused by inflammation. The consequence is passage of serum, with large protein molecules into the suprachoroidal space. Since the protein content of the fluid accumulating in the normally virtual suprachoroidal space is similar to plasma with an equal oncotic pressure, its spontaneous reabsorption is unlikely, unless the underlying cause (ie, inflammation, hypotony) is treated. A breakdown of the blood-aqueous barrier across the pigmented epithelium may cause a superimposed nonrhegmatogenous retinal detachment. As a sequela, linear areas of pigmented epithelium hypertrophy, called Verhoeff streaks, indicate the posterior limits of the retinal detachment after its reabsorption.

Frequency

International

Serous choroidal detachments are recognized easily when large. More subtle, anterior, shallow ciliochoroidal detachments, although relatively common after glaucoma filtration surgery, are undetected or unreported. Suprachoroidal hemorrhage is a rare occurrence. Reported data vary between 0.05-6%, depending on the sample. See Causes for predisposing factors.

Mortality/Morbidity

No mortality has been reported. Morbidity in serous choroidal detachment is significant. In phakic eyes, lens opacities can progress rapidly. Cyclitic pupillary membranes may develop. When a flat chamber is present, corneal endothelial damage and peripheral anterior synechiae can occur. Chronic choroidal detachment can lead to maculopathy and globe phthisis. In hemorrhagic detachment, morbidity is the same as for serous detachment, but the prognosis is worse. Loss of useful vision is reported in up to 40% of cases.

Race

No racial predilection exists.

Sex

No sexual predilection exists.

Age

Hemorrhagic detachments are seen more often in elderly patients.



History

  • Rarely, choroidal detachments form spontaneously. Recent intraocular surgery is the most common association. Eye trauma and corneal ulcers are frequent, and panretinal photocoagulation can also cause choroidal detachments. The use of IOP-lowering medications has also reportedly been associated with serous choroidal detachments.
  • Serous detachment is typically painless, with a variable degree of vision loss.
  • Postoperative hemorrhagic detachments are characterized by sudden excruciating throbbing pain with an immediate loss of vision; both symptoms are almost pathognomonic.
  • Detachment can occur after a Valsalva maneuver, straining at stools, coughing, or sneezing. Anticoagulants and aspirin may facilitate bleeding.
  • Intraoperative hemorrhage is characterized by the development of positive pressure, visualization of an enlarging dark mass obscuring the fundus reflex, and tendency to extrude eye contents.
  • Ciliochoroidal edema/detachment without evidence of intraocular surgery or trauma should be investigated for a neoplastic, vascular, or inflammatory cause.
  • Visual acuity usually is reduced, including light perception, depending on the degree of interference with the visual axis.
  • Inflammation in the anterior and posterior segment varies.
  • Intraocular pressure can be normal, low, or elevated; as a rule, low IOP accompanies serous detachments, and high IOP accompanies hemorrhages.

Physical

  • The anterior chamber (AC) can be of normal depth, or it can be shallow or flat.
  • When no other causes for hypotony are evident after trauma or surgery, use gonioscopy to check for a cyclodialysis cleft.
  • The fundus examination shows choroidal detachment (see Media file 1).
  • Stage the detachment (see Media file 3).
    • The extent of detachment can be limited to one or more sectors, with the lobe(s) limited by the fibrous attachments corresponding to the vortex veins.
    • Annular detachments involve the circumference for 360°.
    • A large degree of fluid accumulation can cause contact between lobes on the visual axis, with retina-to-retina contact centrally (kissing choroidals), while little fluid accumulation can cause a flat and anterior detachment, visible only with ultrasound biomicroscopy (UBM).
  • Suprachoroidal hemorrhages can be accompanied by vitreous hemorrhage, retinal detachment, and retinal breaks.
  • Intraoperative hemorrhages can be complicated by loss of eye contents, resulting in vitreous, retina, or lens remnants incarcerated in the surgical incision or visible in the AC (see Media file 4).  
  • Retinal detachment on ophthalmoscopy
    • A nonrhegmatogenous retinal detachment can be superimposed to a choroidal detachment and characterized by shifting subretinal fluid.
    • Choroidal detachments are nontremulous.
    • Retinal vessels look normal.
    • Ora serrata may be visible without indentation.
  • B-scan ultrasonography
    • Retinal detachments are mobile and highly reflective.
    • Choroidal detachments are domed shaped and are serous or hemorrhagic.
  • Chronic serous choroidal detachments
    • Solid intraocular tumors are identified by transillumination.
    • With serous detachments, transillumination reveals a bright reflex, which can be present in nonpigmented choroidal melanomas.

Causes

  • Serous detachments have no specific predisposing factors except nanophthalmos.
  • Causes of serous detachments include globe hypotony, trauma, and inflammation.
  • Predisposing factors for choroidal hemorrhages are old age, diffuse arteriosclerosis, glaucoma, previous eye surgery, axial myopia, a choroidal hemorrhage in the fellow eye, sickle cell anemia, and very short axial length.
  • Postoperative hypotony is the most likely causal factor.
  • Hemorrhage occurs when vessels rupture. Hemorrhage is more likely in patients with systemic hypertension, intraoperative tachycardia, or arteriosclerosis. Other predisposing factors include old age and previous eye surgery.
  • Sudden globe decompression during surgery, particularly if the eye is affected by glaucoma and surgery is initiated when the IOP is still elevated, also predisposes to choroidal detachment.
  • The use of some medications has also reportedly been associated with serous choroidal detachments.



Glaucoma, Malignant
Melanoma, Choroidal
Pupillary Block, Aphakic
Pupillary Block, Pseudophakic
Retinal Detachment, Exudative
Retinal Detachment, Postoperative
Retinal Detachment, Tractional

Other Problems to be Considered

Aqueous misdirection (No choroidal detachment is present.)
Pupillary block (No choroidal detachment is present.)



Imaging Studies

  • B-scan ultrasonography can aid in differentiating between serum and blood collected under or within the choroid (see Media file 2).



Medical Care

As soon as the diagnosis is confirmed, topical corticosteroids, cycloplegics, and mydriatics should be prescribed for patients. Oral steroids can be used and are indicated when inflammation is a factor. When the IOP is high, which can occur with hemorrhagic choroidal detachments, IOP-lowering drugs can be used. Osmotics and aqueous suppressants are recommended. Parasympathomimetics are contraindicated.

Surgical Care

If choroidal detachment persists longer than 1 week after the underlying cause has been identified and addressed, drainage of the suprachoroidal fluid should be considered. The 7-day limit is an indication only; individualized assessment is key. If an improvement is suspected, waiting longer and closely monitoring the patient may be warranted. Immediate action is indicated when lens-cornea touch or IOL-cornea touch exists. This condition causes endothelial corneal damage and acceleration of lens opacities.

  • If the AC remains flat after the cause has been identified and addressed, injection of viscoelastics into the AC should be considered. If lens-cornea touch or IOL-cornea touch exists, the AC reformation should be performed immediately, at the slit lamp if possible, while waiting to assess the need for suprachoroidal fluid drainage.
    • The AC reformation at the slit lamp is best performed through a paracentesis tract in the peripheral cornea; paracentesis tracts usually are made at the time of cataract or glaucoma surgery.
    • If not present, a paracentesis should be made with extreme care because the eye is likely to be soft and sore with a peripherally flat chamber; otherwise, inadvertent iris and lens damage may result. Performing a small full thickness corneal incision with a sharp 15° knife is safer.
    • A cooperative patient is mandatory if the procedure is to be performed safely at the slit lamp.
  • The technique for suprachoroidal fluid drainage involves making a paracentesis in the peripheral cornea. A balanced salt solution (BSS) is injected to fill the AC. The paracentesis site made at the time of cataract or glaucoma surgery can be used.
    • Preoperatively, the sectors where the most fluid is accumulated should be identified by ophthalmoscopy or B-scan ultrasonography.
    • Beginning with the sector where the detachment is largest, posterior sclerostomy is performed at 4-5 mm from the limbus. Circumferential cuts are made, producing an incision of about 2 mm in length.
    • As soon as the suprachoroidal space is reached, the fluid drains. Serous detachments drain clear yellow fluid. Hemorrhagic detachments drain dark red fluid, often particulated with blood clots. Gentle poking with a blunt instrument a few millimeters around the sclerostomy helps drainage when spontaneous flow slows down.
    • After one quadrant is drained, the AC is filled again with BSS, and the second quadrant receives a posterior sclerostomy in the same fashion. This procedure can be repeated for all 4 quadrants.
    • At the end, especially in highly myopic eyes without a lens, SF6 gas can be left in the vitreous cavity to tamponade. No agreement exists regarding the closure of sclerostomies, which some surgeons elect to leave unsutured to allow for more drainage.



The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Drug Category: Anticholinergic agents

Inhibit binding of acetylcholine to cholinergic receptor, which, in turn, produces cycloplegia and mydriasis.

Drug NameCyclopentolate hydrochloride 1% (AK-Pentolate, Cyclogyl, I-Pentolate)
DescriptionBlocks muscle of ciliary body and sphincter muscle of iris from responding to cholinergic stimulation, thus causing mydriasis and cycloplegia.
Induces mydriasis in 30-60 min and cycloplegia in 25-75 min. These effects last up to 24 h.
Adult Dose1 gtt of 1% solution usually adequate to induce cycloplegia; if necessary, repeat in 5-10 min
Pediatric Dose<1 year: 1 gtt of 0.5% solution with digital pressure on lacrimal sac
>1 year: 1 gtt of 0.5%, 1%, or 2% solution to induce cycloplegia; if necessary, repeat in 5-10 min
ContraindicationsDocumented hypersensitivity; narrow-angle glaucoma
InteractionsDecreases effects of carbachol and cholinesterase inhibitors
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in patients (eg, elderly) where increased IOP may be present; can cause toxic anticholinergic systemic adverse effects (common in children, especially infants) but incidence rare when used sparingly; compressing lacrimal sac by digital pressure for 1-3 min, following application, may minimize systemic absorption; skin rash, abdominal distension in infants, tachycardia, vasodilation, urinary retention, diminished GI motility, decreased secretion in salivary and sweat glands, pharynx, bronchi, and nose may occur

Drug NameAtropine sulfate 1% (Isopto, Atropair, Atropisol)
DescriptionActs at parasympathetic sites in smooth muscle to block response of sphincter muscle of iris and muscle of ciliary body to acetylcholine, causing mydriasis and cycloplegia.
Adult DoseSolution (1%): 1-2 gtt in affected eye(s) qid; compress lacrimal sac by digital pressure for 1-3 min after instillation
Ointment: Apply 0.5-inch ribbon in conjunctival sac tid
Pediatric DoseSolution (0.5%): 1-2 gtt in affected eye(s) bid/tid
Ointment: Not established
ContraindicationsDocumented hypersensitivity; thyrotoxicosis; narrow angle glaucoma; tachycardia
InteractionsCoadministration with other anticholinergics have additive effects; pharmacologic effects of atenolol and digoxin may increase with atropine; antipsychotic effects of phenothiazines may decrease; tricyclic antidepressants with anticholinergic activity may increase effects of atropine
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsExtreme caution in infants and children; excessive use in children and certain susceptible individuals may produce general toxic symptoms, including CNS disturbances, respiratory depression, and hypotension; coma and death reported in infants; caution in patients with Down syndrome and/or children with brain damage to prevent hyperreactive response; caution in coronary heart disease, tachycardia, congestive heart failure, cardiac arrhythmias, and hypertension; caution in peritonitis, ulcerative colitis, hepatic disease, and hiatal hernia with reflux esophagitis; in prostatic hypertrophy, prostatism can have dysuria and may require catheterization; prolonged local administration can cause vascular congestion, follicular conjunctivitis, exudates, edema, and eczematoid dermatitis

Drug Category: Mydriatic agents

Instillation of a long-acting cycloplegic agent relaxes any ciliary muscle spasm that causes a deep aching pain and photophobia.

Drug NameTropicamide 1% (Mydriacyl, Tropicacyl)
DescriptionBlocks sphincter muscle of iris and muscle of ciliary body from responding to cholinergic stimulation.
Adult DoseCycloplegia: 2 gtt in affected eye(s); may repeat in 5 min
Mydriasis: 1-2 gtt in affected eye(s) 15-20 min before examination; may repeat q30min prn
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCNS disturbances, psychotic reactions, behavioral disturbances, and cardiorespiratory collapse (especially in infants) may occur; adverse effects include transient stinging, blurred vision, mouth dryness, photophobia with or without corneal staining, tachycardia, parasympathetic stimulation, headache, and allergic reactions

Drug Category: Corticosteroids

Have both anti-inflammatory (glucocorticoid) and salt-retaining (mineralocorticoid) properties. Glucocorticoids have profound and varied metabolic effects. In addition, these agents modify the body's immune response to diverse stimuli.

Drug NamePrednisone (Deltasone, Orasone, Meticorten)
DescriptionMay decrease inflammation by reversing increased capillary permeability and suppressing PMN activity.
Adult Dose5-60 mg/d PO qd or divided bid/qid; taper over 2 wk as symptoms resolve
Pediatric Dose4-5 mg/m2/d PO; alternatively, 0.05-2 mg/kg PO divided bid/qid; taper over 2 wk as symptoms resolve
ContraindicationsDocumented hypersensitivity; viral infection; peptic ulcer disease; hepatic dysfunction; connective tissue infections; fungal or tubercular skin infections; GI disease
InteractionsCoadministration with estrogens may decrease prednisone clearance; concurrent use with digoxin may cause digitalis toxicity secondary to hypokalemia; phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAbrupt discontinuation of glucocorticoids may cause adrenal crisis; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections may occur with glucocorticoid use

Drug NamePrednisolone (AK-Pred, Econopred, Inflamase Forte)
DescriptionDecreases inflammation and corneal neovascularization. Suppresses migration of polymorphonuclear leukocytes and reverses increased capillary permeability.
In cases of bacterial infections, concomitant use of anti-infective agents is mandatory; if signs and symptoms do not improve after 2 days, reevaluate patient. Dosing may be reduced, but advise patients not to discontinue therapy prematurely.
Adult DoseSolution: 1-2 gtt in conjunctival sac q1h during day and q2h noct; once desired response is obtained, 1 gtt q4h; may reduce to 1 gtt tid/qid to control symptoms
Suspension: Shake well before using; 1-2 gtt in conjunctival sac 2-4 times/d; if necessary, may increase dosing frequency during initial 24-48 h
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity; viral, fungal, or tubercular infections
InteractionsNone reported
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in hypertension; known to cause cataract formation with long-term use; suspect fungal invasion in any persistent corneal ulceration where a corticosteroid has been used or is in use (obtain fungal cultures when appropriate)



Further Outpatient Care

  • Monitor visual acuity, AC depth, IOP, and extension of the detachment.
  • After managing the underlying cause, a postoperative totally flat AC with corneal-lenticular touch should be managed surgically. A flat chamber with contact of the corneal endothelium with the lens or pseudophakos can lead to rapid corneal endothelial failure and decompensation, extensive anterior and posterior synechiae, and acceleration of cataract changes in phakic patients. It can also trigger aqueous misdirection.

In/Out Patient Meds

  • Prescribe topical steroids and cycloplegics. Oral steroids may be indicated.
  • Consider topical IOP-lowering agents, oral carbonic anhydrase inhibitors, and systemic osmotics in patients with significant IOP elevation.
  • Avoid anticoagulants or aspirin with suprachoroidal hemorrhage.

Deterrence/Prevention

  • After open globe surgery, particularly glaucoma surgery, hypotony must be avoided by careful suturing techniques.
  • During surgery, take care not to suddenly decompress the globe; use a paracentesis tract to slowly deflate it.
  • Preoperative osmotics or carbonic anhydrase inhibitors can be used to decrease the IOP to a safe level before surgery.

Complications

  • Serous choroidal detachment or suprachoroidal hemorrhage can result in phthisis, retinal detachment, cataract formation, or intractable secondary glaucoma.

Prognosis

  • The prognosis is guarded. In general, a correlation exists between the severity and extension of the detachment and the prognosis.
  • Preexisting eye conditions (eg, advanced glaucoma) influence the final functional outcome.
  • Even with treatment, loss of functional vision can occur in 10-80% of patients.
  • The prognosis for patients with choroidal hemorrhages is worse than for those with serous choroidal detachments, especially when choroidal hemorrhages are intraoperative and where severe functional damage is frequent.



Medical/Legal Pitfalls

  • Choroidal detachments are most frequently a complication of eye surgery; because patients are often malcontent, medicolegal consequences are to be expected. In the chart, accurately describe all findings with drawings and photos, including B-scan ultrasonography examination results, before the initiation of any treatment. Complete and clear explanations to the patient are of utmost value.



Media file 1:  Serous choroidal detachment. Two lobes (ie, supertemporal, supranasal) of fluid accumulation are visible. The choroidal folds seen at the posterior pole are due to concomitant hypotony.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  B-scan ultrasonography examination of choroidal detachment. Fluid appears to be serum on one side (upper) and blood on the other side (below). Retina-to-retina contact, or kissing choroidal detachment, is present.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 3:  Kissing choroidal detachment. When the lobes of the detachment are sufficiently large, retina-to-retina contact occurs. If this is extended centrally, the clinical picture is described as kissing choroidals. The extension of the lobes of detachment/edema is important for the decision-making process regarding the clinical management.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 4:  Postoperative suprachoroidal hemorrhage. In this buphthalmic aphakic eye, suprachoroidal hemorrhage resulted in vitreous hemorrhage, retinal detachment, and extrusion of retina and blood through the pupil into the anterior chamber.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 5:  Drainage of suprachoroidal space. After the posterior sclerostomies are performed, gentle infusion in the anterior chamber through a paracentesis tract helps the globe to maintain a tone while the fluid exit from the suprachoroidal space is facilitated.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Image

Media file 6:  Drainage of suprachoroidal space. The hemorrhagic fluid is darker than fresh blood. Mechanical gaping of the radial incisions facilitates the egress of fluid.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Abrams GW, Thomas MA, Williams GA, Burton TC. Management of postoperative suprachoroidal hemorrhage with continuous-infusion air pump. Arch Ophthalmol. Oct 1986;104(10):1455-8. [Medline].
  • Bellows AR, Chylack LT Jr, Epstein DL, Hutchinson BT. Choroidal effusion during glaucoma surgery in patients with prominent episcleral vessels. Arch Ophthalmol. Mar 1979;97(3):493-7. [Medline].
  • Berke SJ, Bellows AR, Shingleton BJ, Richter CU, Hutchinson BT. Chronic and recurrent choroidal detachment after glaucoma filtering surgery. Ophthalmology. Feb 1987;94(2):154-62. [Medline].
  • Brubaker RF, Pederson JE. Ciliochoroidal detachment. Surv Ophthalmol. Mar-Apr 1983;27(5):281-9. [Medline].
  • Chu TG, Cano MR, Green RL, Liggett PE, Lean JS. Massive suprachoroidal hemorrhage with central retinal apposition. A clinical and echographic study. Arch Ophthalmol. Nov 1991;109(11):1575-81. [Medline].
  • Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B. Loss of visual acuity after trabeculectomy. Ophthalmology. May 1993;100(5):599-612. [Medline].
  • Davani S, Delbosc B, Royer B, Kantelip JP. Choroidal detachment induced by dorzolamide 20 years after cataract surgery. Br J Ophthalmol. Dec 2002;86(12):1457-8. [Medline].
  • Goldberg S, Gallily R, Bishara S, Blumenthal EZ. Dorzolamide-induced choroidal detachment in a surgically untreated eye. Am J Ophthalmol. Aug 2004;138(2):285-6. [Medline].
  • Horgan N, Kirwan RP, O'Brien CJ. Choroidal detachment associated with latanoprost use in the fellow eye. Ann Pharmacother. Jan 2007;41(1):161-2. [Medline].
  • Katz LJ. Ciliochoroidal detachment. Ophthalmic Surg. Mar 1987;18(3):175. [Medline].
  • Maumenee AE, Stark WJ. Management of persistent hypotony after planned or inadvertent cyclodialysis. Am J Ophthalmol. Jan 1971;71(1 Part 2):320-7. [Medline].
  • Shapiro BL, Petrovic V, Lee SE, Flach A, McCaffery S, O'Brien JM. Choroidal detachment following the use of tamsulosin (Flomax). Am J Ophthalmol. Feb 2007;143(2):351-3. [Medline].
  • Sharma T, Gopal L, Reddy RK, Kasinathan N, Shah NA, Sulochana KN, et al. Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study. Retina. Feb-Mar 2005;25(2):152-7. [Medline].
  • Sharma T, Salmon JF. Hypotony and choroidal detachment as a complication of topical combined timolol and dorzolamide. J Ocul Pharmacol Ther. Apr 2007;23(2):202-5. [Medline].
  • Singh R, Umapathy T, Abedin A, Eatamadi H, Maharajan S, Dua HS. Choroidal detachment in perforated corneal ulcers: frequency and management. Br J Ophthalmol. Sep 2006;90(9):1111-4. [Medline].
  • Sodhi PK, Sachdev MS, Gupta A, Verma LK, Ratan SK. Choroidal detachment with topical latanoprost after glaucoma filtration surgery. Ann Pharmacother. Mar 2004;38(3):510-1. [Medline].
  • Speaker MG, Guerriero PN, Met JA, Coad CT, Berger A, Marmor M. A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage. Ophthalmology. Feb 1991;98(2):202-9; discussion 210. [Medline].
  • Stalmans I, Gillis A, Lafaut AS, Zeyen T. Safe trabeculectomy technique: long term outcome. Br J Ophthalmol. Jan 2006;90(1):44-7. [Medline].
  • Verma L, Venkatesh P, Chawla R, Tewari HK. Choroidal detachment following retinal detachment surgery: an analysis and a new hypothesis to minimize its occurrence in high-risk cases. Eur J Ophthalmol. Jul-Aug 2004;14(4):325-9. [Medline].
  • Yalvac IS, Satana B, Ozkan G, Eksioglu U, Duman S. Management of glaucoma in patients with nanophthalmos. Eye. Feb 9 2007;[Medline].

Choroidal Detachment excerpt

Article Last Updated: Sep 11, 2007